Consumer Staples

Ispire Technology reports mixed first-quarter fiscal 2027 results as margin improves

Ispire Technology reported a sequential recovery in gross margin and Adjusted EBITDA during the first quarter of fiscal 2027, while revenue declined year on year and cash balances fell from the previous fiscal year-end.

Published:
Reading Time
3 min

Ispire Technology Inc. (Nasdaq:ISPR) reported a sequential improvement in gross margin, net loss and Adjusted EBITDA for the first quarter of fiscal 2027, although revenue declined from the year-ago period and the company ended the quarter with lower cash and working capital than at the previous fiscal year-end.

#Revenue declined year on year

For the three months ended September 30, 2026, revenue was $27.5 million. That was down 9.3% from $30.4 million in the first quarter of fiscal year 2026. Ispire said the decrease was primarily linked to lower European sales amid what it described as an increasingly restrictive regulatory environment for vaping products.

Revenue increased 3.2% from $26.7 million in the fourth quarter of fiscal 2026.

#Gross margin recovered from the prior quarter

Gross profit was $4.5 million, compared with $5.1 million in the year-ago quarter. Gross margin was 16.2%, versus 17.0% in the first quarter of fiscal year 2026 and 6.3% in the preceding quarter.

The company attributed the sequential improvement to the one-time inventory impairment and returns charges recorded in the fourth quarter of fiscal 2026.

#Net loss included credit loss expense

Ispire reported a GAAP net loss of $6.4 million, or ($0.11) per share, compared with a net loss of $3.3 million, or ($0.06) per share, in the year-ago period. The current-quarter result included $4.8 million of credit loss expense.

Total operating expenses were $10.6 million, up from $7.8 million in the first quarter of fiscal year 2026. The company said the increase was driven primarily by non-cash credit loss expenses. Credit loss expense was $4.8 million, compared with $1.8 million in the year-ago quarter.

#Adjusted EBITDA returned to positive territory

Adjusted EBITDA, a non-GAAP measure, was $136,000 for the quarter. This compared with $0.6 million in the first quarter of fiscal 2026 and an Adjusted EBITDA loss of ($2.3) million in the previous quarter.

Ispire said the sequential improvement reflected the recovery in gross margin. The company cautions that Adjusted EBITDA should not be viewed as a substitute for results prepared under U.S. GAAP and may not be comparable with similarly named measures used by other companies.

#Cash and receivables

At September 30, 2026, Ispire held cash of $15.6 million and working capital of $0.4 million. Compared with the fiscal year ended June 30, 2026, cash decreased by $3.7 million and working capital decreased by $0.4 million.

The company said net accounts receivable had fallen by approximately 80% from peak levels in fiscal 2025. It attributed the reduction to collections, allowances for credit losses against outstanding balances, and changes to customer credit standards and payment terms.

#Malaysia, OEM and ODM initiatives

Ispire said it is investing in its Malaysia manufacturing facility during fiscal year 2027 while pursuing additional original equipment manufacture and original design manufacture relationships. The company also identified its Vapor OEM and ODM pipeline, G-Mesh technology, IKE Tech's age-gating platform and its nicotine pouch joint venture with Jincheng Pharma as areas being advanced.

Management said it believes the company is close to securing a significant OEM and ODM relationship with a well-known regional brand in Southeast Asia. The relationship has not been stated as secured; Ispire said it hopes to provide an update in the coming months.

Ispire also said IKE Tech is advancing commercialisation efforts that include a planned U.S. pilot of its IKE 2.0 age-gating platform with Charlie's Holdings. The company said it remains focused on achieving cash-flow-positive performance, while management expects cash flow to improve as new manufacturing and commercial programmes begin to scale. Its forward-looking disclosures state that the timing of positive cash flow remains uncertain and may occur, if at all.

#About Ispire Technology

Ispire researches, develops, designs, commercialises, sells, markets and distributes branded e-cigarettes and cannabis vaping products. Its e-cigarette products are marketed under the Aspire name, while its cannabis products are marketed under the Ispire brand, primarily through original design manufacture relationships.

#Key Takeaways

  • First-quarter fiscal 2027 revenue was $27.5 million, down 9.3% year on year but up 3.2% sequentially.
  • Gross margin improved to 16.2% from 6.3% in the prior quarter.
  • GAAP net loss was $6.4 million, or ($0.11) per share, including $4.8 million of credit loss expense.
  • Adjusted EBITDA was $136,000, compared with an Adjusted EBITDA loss of ($2.3) million in the preceding quarter.
  • Ispire reported cash of $15.6 million and working capital of $0.4 million at September 30, 2026.

Original source: Read original article

Frequently Asked Questions